Hua Linghu

604 total citations
34 papers, 415 citations indexed

About

Hua Linghu is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Surgery. According to data from OpenAlex, Hua Linghu has authored 34 papers receiving a total of 415 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Reproductive Medicine, 12 papers in Obstetrics and Gynecology and 11 papers in Surgery. Recurrent topics in Hua Linghu's work include Ovarian cancer diagnosis and treatment (14 papers), Endometrial and Cervical Cancer Treatments (11 papers) and Intraperitoneal and Appendiceal Malignancies (7 papers). Hua Linghu is often cited by papers focused on Ovarian cancer diagnosis and treatment (14 papers), Endometrial and Cervical Cancer Treatments (11 papers) and Intraperitoneal and Appendiceal Malignancies (7 papers). Hua Linghu collaborates with scholars based in China and Japan. Hua Linghu's co-authors include Ruonan Li, Bin Liu, Bin Liu, Shinya Tanaka, Masumi Tsuda, Lin Zhou, Lijuan Cheng, Jin Wang, Yimeng Gao and Naoki Mochizuki and has published in prestigious journals such as Oncogene, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Hua Linghu

33 papers receiving 410 citations

Peers

Hua Linghu
Marta Bellone Italy
Suiqun Guo China
Yinhua Yu China
Rika Okamoto Japan
Jane Cipollone Canada
Lorena Alonso‐Alconada Spain
Rachel A. Davidowitz United States
Chandramohan S. Ishwad United States
Eslam A. Elghonaimy Egypt
Marta Bellone Italy
Hua Linghu
Citations per year, relative to Hua Linghu Hua Linghu (= 1×) peers Marta Bellone

Countries citing papers authored by Hua Linghu

Since Specialization
Citations

This map shows the geographic impact of Hua Linghu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hua Linghu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hua Linghu more than expected).

Fields of papers citing papers by Hua Linghu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hua Linghu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hua Linghu. The network helps show where Hua Linghu may publish in the future.

Co-authorship network of co-authors of Hua Linghu

This figure shows the co-authorship network connecting the top 25 collaborators of Hua Linghu. A scholar is included among the top collaborators of Hua Linghu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hua Linghu. Hua Linghu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huang, Ying, et al.. (2024). Early salvage therapy with anti-PD-1 antibody Camrelizumab in patients with advanced cervical cancer: a retrospective study. Clinical & Translational Oncology. 27(2). 693–698. 2 indexed citations
2.
Xiao, Yao, et al.. (2024). Prognostic Value of Ki67 in Epithelial Ovarian Cancer: Post-Neoadjuvant Chemotherapy Ki67 Combined with CA125 Predicting Recurrence. Cancer Management and Research. Volume 16. 761–769. 1 indexed citations
3.
Yang, Jing, Dan Li, Hua Linghu, et al.. (2024). Exploring a multiparameter MRI–based radiomics approach to predict tumor proliferation status of serous ovarian carcinoma. Insights into Imaging. 15(1). 74–74. 3 indexed citations
4.
Wang, Jinlong, et al.. (2024). Low PDE4A expression promoted the progression of ovarian cancer by inducing Snail nuclear translocation. Experimental Cell Research. 439(2). 114100–114100. 2 indexed citations
5.
Linghu, Hua, et al.. (2023). Survival Outcomes of Patients with International Federation of Gynecology and Obstetrics Stage IV Ovarian Cancer: Cytoreduction Still Matters. Cancer Control. 30. 2915577826–2915577826. 1 indexed citations
6.
7.
Liu, Yue-Xi, et al.. (2022). Computed tomographic enterography (CTE) in evaluating bowel involvement in patients with ovarian cancer. Abdominal Radiology. 47(6). 2023–2035. 1 indexed citations
8.
Xu, Jie, Can Chen, Jing Xiong, Hui Wang, & Hua Linghu. (2021). Predictive Value of Serum Cytokeratin 19 Level for the Feasibility of Conserving Ovaries in Endometrial Cancer. Frontiers in Medicine. 8. 670109–670109. 6 indexed citations
9.
10.
Xu, Jie, Can Chen, Jing Xiong, & Hua Linghu. (2020). <p>Differential Impact of Systemic Lymphadenectomy Upon the Survival of Patients with Type I vs Type II Endometrial Cancer: A Retrospective Observational Cohort Study</p>. Cancer Management and Research. Volume 12. 12269–12276. 2 indexed citations
11.
12.
Wu, Jin, et al.. (2019). <p>WHSC1 acts as a prognostic indicator and functions as an oncogene in cervical cancer</p>. OncoTargets and Therapy. Volume 12. 4683–4690. 12 indexed citations
13.
Zhou, Lin, Lijuan Cheng, Ruonan Li, et al.. (2019). ALPL regulates the aggressive potential of high grade serous ovarian cancer cells via a non-canonical WNT pathway. Biochemical and Biophysical Research Communications. 513(2). 528–533. 16 indexed citations
14.
15.
Li, Gang, Min Cheng, Yimeng Gao, et al.. (2015). The C3G/Rap1 pathway promotes secretion of MMP-2 and MMP-9 and is involved in serous ovarian cancer metastasis. Cancer Letters. 359(2). 241–249. 47 indexed citations
16.
Wang, Hui, Hua Linghu, Jin Wang, et al.. (2009). The role of Crk/Dock180/Rac1 pathway in the malignant behavior of human ovarian cancer cell SKOV3. Tumor Biology. 31(1). 59–67. 31 indexed citations
17.
Wang, Lei, Kouichi Tabu, Taichi Kimura, et al.. (2007). Signaling adaptor protein Crk is indispensable for malignant feature of glioblastoma cell line KMG4. Biochemical and Biophysical Research Communications. 362(4). 976–981. 36 indexed citations
18.
Linghu, Hua, Masumi Tsuda, Yoshinori Makino, et al.. (2006). Involvement of adaptor protein Crk in malignant feature of human ovarian cancer cell line MCAS. Oncogene. 25(25). 3547–3556. 48 indexed citations
19.
Linghu, Hua, et al.. (2004). Changes of soluble fas and soluble fas ligand in serum and peritoneal fluid of infertile patients with endometriosis.. PubMed. 19(1). 56–9. 5 indexed citations
20.
Linghu, Hua, et al.. (2003). Short-time analysis for adjuvant chemotherapy in patients with early-stage bulky cervical carcinoma. Chinese Journal of Cancer Research. 15(2). 144–148. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marta Bellone Breakdown of academic impact, for papers by Suiqun Guo Breakdown of academic impact, for papers by Yinhua Yu Breakdown of academic impact, for papers by Rika Okamoto Breakdown of academic impact, for papers by Jane Cipollone Breakdown of academic impact, for papers by Lorena Alonso‐Alconada Breakdown of academic impact, for papers by Rachel A. Davidowitz Breakdown of academic impact, for papers by Chandramohan S. Ishwad Breakdown of academic impact, for papers by Eslam A. Elghonaimy
Rankless by CCL
2026